Comparative clinical study of josamycin and erythromycin in pertussis.
Forty children with pertussis were treated in a randomized trial with josamycin or erythromycin. The pathogen was isolated in 15 cases by immunofluorescent antibody (IFA) technique. The clinical response of both groups was good and comparable. A 15-day course of therapy was able to eradicate the pathogen in all but one patient. Three patients showed minor side effects: diarrhea (2), rash (1).